FDA To Study Television Drug Ads
Under current regulations, pharmaceutical companies must include a “fair balance” of information in their direct-to-consumer advertising. However, many health care providers and consumers have expressed concern about the “compelling visuals” contained in the ads, according to the U.S. Food and Drug Administration.
“Ads can present information in ways that can optimize or skew the relative balance of risks and benefits,” the FDA said Wednesday...
To view the full article, register now.